Literature DB >> 12574882

[Evaluation of symptoms in men with chronic pelvic pain].

W W Hochreiter1, P Hruz, H Danuser, W Weidner, U E Studer.   

Abstract

According to the National Institutes of Health classification system, chronic non-bacterial prostatitis/chronic pelvic pain syndrome (CPPS) is subdivided into an inflammatory (category IIIa) and a non-inflammatory (category IIIb) form. The difference is based on the presence or absence of white blood cells in expressed prostatic secretions, urine after prostatic massage, or semen. This is the only criterion which allows a differentiation between the IIIa and IIIb forms. The symptoms, i.e. pain and urinary complaints of various degrees, are thought to be similar in both forms. These symptoms can be assessed with the Chronic Prostatitis Symptom Index (CPSI) and the International Prostate Symptom Score (IPSS), which are both available in a validated German translation. One hundred and six patients with CPPS were evaluated with CPSI and IPSS. Urinary symptoms troubled all patients. Men with category IIIa had significantly more urinary symptoms when compared to men with category IIIb. There was no difference between the two groups regarding pain and impact on the quality of life. Although pain is thought to be the hallmark of CPPS, the contribution of urinary troubles to the symptoms must not be underestimated.

Entities:  

Mesh:

Year:  2002        PMID: 12574882     DOI: 10.1007/s00120-002-0264-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  9 in total

1.  NIH consensus definition and classification of prostatitis.

Authors:  J N Krieger; L Nyberg; J C Nickel
Journal:  JAMA       Date:  1999-07-21       Impact factor: 56.272

2.  [National Institutes of Health (NIH) Chronic Prostatitis Symptom Index. The German version].

Authors:  W Hochreiter; M Ludwig; W Weidner; F Wagenlehner; K Naber; S Eremenco; B Arnold
Journal:  Urologe A       Date:  2001-01       Impact factor: 0.639

3.  Chronic prostatitis: results of an Internet survey.

Authors:  R B Alexander; D Trissel
Journal:  Urology       Date:  1996-10       Impact factor: 2.649

4.  Sickness impact of chronic nonbacterial prostatitis and its correlates.

Authors:  K Wenninger; J R Heiman; I Rothman; J P Berghuis; R E Berger
Journal:  J Urol       Date:  1996-03       Impact factor: 7.450

5.  [Symptoms of prostatitis in German. The Giessen Prostatitis Symptom Score].

Authors:  E Brähler; J Kupfer; M Ludwig; W Weidner
Journal:  Urologe A       Date:  2001-01       Impact factor: 0.639

6.  The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network.

Authors:  M S Litwin; M McNaughton-Collins; F J Fowler; J C Nickel; E A Calhoun; M A Pontari; R B Alexander; J T Farrar; M P O'Leary
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

Review 7.  Chronic abacterial prostatitis--a urological chronic pain syndrome?

Authors:  Kelly J Egan; John L Krieger
Journal:  Pain       Date:  1997-02       Impact factor: 6.961

8.  Diagnosis and treatment of 409 patients with prostatitis syndromes.

Authors:  J J de la Rosette; M R Hubregtse; E J Meuleman; M V Stolk-Engelaar; F M Debruyne
Journal:  Urology       Date:  1993-04       Impact factor: 2.649

9.  Prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2,096 men.

Authors:  S Madersbacher; G Haidinger; C Temml; C P Schmidbauer
Journal:  Eur Urol       Date:  1998-08       Impact factor: 20.096

  9 in total
  2 in total

Review 1.  [Dynamic bladder neck stenosis as a cause of psychogenic mictrition discomforts and mictrition disorders].

Authors:  E-A Günthert
Journal:  Urologe A       Date:  2004-05       Impact factor: 0.639

2.  Experience with different questionnaires in the management of patients with CP/CPPS: GPSS, IPSS and NIH-CPSI.

Authors:  Henning Schneider; Martin Ludwig; Wolfgang Weidner; Elmar Brähler
Journal:  World J Urol       Date:  2003-05-24       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.